Stock-Based Compensation

6 Months Ended

Jun. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months ended June 30, 2015 and 2014, was as follows:



	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2015		2014		2015		2014
Cost of goods sold	$	226	$	197	$	474	$	404
Operating expenses:
Research and development	258		185		486		335
Clinical and regulatory affairs	243		365		428		262
Marketing and sales	839		645		1,587		1,194
General and administrative	842		748		1,644		1,558
Total operating expenses	$	2,182	$	1,943	$	4,145	$	3,349
Total	$	2,408	$	2,140	$	4,619	$	3,753